MAYZENT FILM-COATED TABLET 0.25MG

Product Information

Registration Status: Active

MAYZENT FILM-COATED TABLET 0.25MG is approved to be sold in Singapore with effective from 2020-11-16. It is marketed by NOVARTIS (SINGAPORE) PTE LTD, with the registration number of SIN16040P.

This product contains Siponimod 0.25mg in the form of TABLET, FILM COATED. It is approved for ORAL use.

This product is manufactured by NOVARTIS PHARMA STEIN AG in SWITZERLAND, andNOVARTIS FARMACÉUTICA SA (primary packager and secondary packager) in SPAIN.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Siponimod

Description

Siponimod has been used in trials studying the treatment of Polymyositis, Dermatomyositis, Renal Impairment, Hepatic Impairment, and Autoimmune Diseases, among others.

Active Ingredient/Synonyms

Siponimod | Siponimod |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank